Chang TJ - Search Results

1

Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study.

Chang CH, Shau WY, Jiang YD, Li HY, Chang TJ, Sheu WH, Kwok CF, Ho LT, Chuang LM. Chang CH, et al. Among authors: chang tj. Diabet Med. 2010 Jun;27(6):636-43. doi: 10.1111/j.1464-5491.2010.03007.x. Diabet Med. 2010. PMID: 20546280

2

Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population.

Chang TJ, Lei HH, Yeh JI, Chiu KC, Lee KC, Chen MC, Tai TY, Chuang LM. Chang TJ, et al. Clin Endocrinol (Oxf). 2000 May;52(5):575-80. doi: 10.1046/j.1365-2265.2000.00985.x. Clin Endocrinol (Oxf). 2000. PMID: 10792336

3

Germline RET proto-oncogene mutations in two Taiwanese families with multiple endocrine neoplasia type 2A.

Wu SL, Chang TC, Huang CN, Chuang LM, Chang TJ. Wu SL, et al. Among authors: chang tc, chang tj. J Formos Med Assoc. 1998 Sep;97(9):614-8. J Formos Med Assoc. 1998. PMID: 9795529

4

Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway.

Yang C, Chang TJ, Chang JC, Liu MW, Tai TY, Hsu WH, Chuang LM. Yang C, et al. Among authors: chang jc, chang tj. Diabetes. 2001 Nov;50(11):2598-602. doi: 10.2337/diabetes.50.11.2598. Diabetes. 2001. PMID: 11679440

5

Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.

Liu RS, Chou TK, Chang CH, Wu CY, Chang CW, Chang TJ, Wang SJ, Lin WJ, Wang HE. Liu RS, et al. Among authors: chang cw, chang tj, chang ch. Nucl Med Biol. 2009 Apr;36(3):305-12. doi: 10.1016/j.nucmedbio.2008.12.011. Nucl Med Biol. 2009. PMID: 19324276

6

Intercomparison of conventional and QuickScan dicentric scoring for the validation of individual biodosimetry analysis in Taiwan.

Lin WC, Chang KW, Liao TZ, Ou Yang FY, Chang TJ, Yuan MC, Wilkins RC, Chang CH. Lin WC, et al. Among authors: chang kw, chang tj, chang ch. Int J Radiat Biol. 2021;97(7):916-925. doi: 10.1080/09553002.2021.1928789. Epub 2021 Jun 1. Int J Radiat Biol. 2021. PMID: 34003708

7

Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model.

Chang YJ, Chang CH, Yu CY, Chang TJ, Chen LC, Chen MH, Lee TW, Ting G. Chang YJ, et al. Among authors: chang tj, chang ch. Nucl Med Biol. 2010 Jan;37(1):95-104. doi: 10.1016/j.nucmedbio.2009.08.006. Epub 2009 Oct 3. Nucl Med Biol. 2010. PMID: 20122674

8

Correlation between radioactivity and chemotherapeutics of the (111)In-VNB-liposome in pharmacokinetics and biodistribution in rats.

Lee WC, Chang CH, Huang CM, Wu YT, Chen LC, Ho CL, Chang TJ, Lee TW, Tsai TH. Lee WC, et al. Among authors: chang tj, chang ch. Int J Nanomedicine. 2012;7:683-92. doi: 10.2147/IJN.S28279. Epub 2012 Feb 9. Int J Nanomedicine. 2012. PMID: 22359447 Free PMC article.

9

External beam radiotherapy synergizes ¹⁸⁸Re-liposome against human esophageal cancer xenograft and modulates ¹⁸⁸Re-liposome pharmacokinetics.

Chang CH, Liu SY, Chi CW, Yu HL, Chang TJ, Tsai TH, Lee TW, Chen YJ. Chang CH, et al. Among authors: chang tj. Int J Nanomedicine. 2015 May 19;10:3641-9. doi: 10.2147/IJN.S80302. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26056445 Free PMC article.

10

Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.

Chang CH, Stabin MG, Chang YJ, Chen LC, Chen MH, Chang TJ, Lee TW, Ting G. Chang CH, et al. Among authors: chang yj, chang tj. Cancer Biother Radiopharm. 2008 Dec;23(6):749-58. doi: 10.1089/cbr.2008.0489. Cancer Biother Radiopharm. 2008. PMID: 19111045

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters